Interaction between midazolam and epibatidine in spinally mediated antinociception in rats

Journal of Anesthesia

Volumn 23, Issue 3, 2009, Pages 370-377

  Nishiyama, Tomoki ^a,b  

^a Kamagaya General Hospital   (Japan)

^b NONE   (Japan)

Author keywords

Antinociception; Gamma aminobutyric acidA receptor; Nicotiniccholinergic receptor; Spinal cord

Indexed keywords

EPIBATIDINE; FORMALDEHYDE; MIDAZOLAM;

AGITATION; ALLODYNIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; FLACCID PARALYSIS; GABAERGIC SYSTEM; MALE; NONHUMAN; PRESYNAPTIC INHIBITION; RAT; RIGHTING REFLEX; SPINAL CORD; SPRAGUE DAWLEY RAT; TAIL FLICK TEST;

ANALGESICS, NON-NARCOTIC; ANESTHESIA, SPINAL; ANESTHETICS, INTRAVENOUS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; FORMALDEHYDE; INJECTIONS, SPINAL; MALE; MIDAZOLAM; PAIN MEASUREMENT; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, GABA-A;

EID: 69049106622     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-009-0765-0     Document Type: Article

References (28)

1. Edwards M, Serrao JM, Gent JP, Goodchild CS. On the mechanism by which midazolam causes spinally mediated analgesia. Anesthesiology. 1990;73:273-277.
2. Nishiyama T. Analgesic effects of systemic midazolam: Comparison with intrathecal administration. Can J Anaesth. 2006;53:1004-1009.
3. Serrao JM, Marks RL, Morley SJ, Goodchild CS. Intrathecal midazolam for the treatment of chronic mechanical low back pain: A controlled comparison with epidural steroid in a pilot study. Pain. 1992;48:5-12.
4. Nishiyama T, Yokoyama T, Hanaoka K. Midazolam improves postoperative epidural analgesia with continuous infusion of local anaesthetics. Can J Anaesth. 1998;45:551-555.
5. Molinero MT, Del Rio J. Substance P, nicotinic acetylcholine receptors and antinociception in the rat. Neuropharmacology. 1987;26:1715-1720.
6. Lawand NB, Lu Y, Westlund KN. Nicotinic cholinergic receptors: Potential targets for inflammatory pain relief. Pain. 1990;80:291-299.
7. Phan DV, Doda M, Bite A, Gyorgy I. Antinociceptive activity of nicotine. Acta Physiol Acad Sci Hung. 1973;1:85-93.
8. Sullivan JP, Bannon AW. Epibatidine: Pharmacological properties of a novel nicotinic acetylcholine receptor agonist and analgesic agent. CNS Drugs. 1996;2:21-39.
9. Nishiyama T, Gyermek L, Trudell ML, Hanaoka K. Spinally mediated analgesia and receptor binding affinity of epibatidine analogs. Eur J Pharmacol. 2003;470:27-31.
10. Bonhaus AW, Bley KR, Broka CA, Fontana DJ, Leung E, Lewis R, Shieh A, Wong EH. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. J Pharmacol Exp Ther. 1995;272:1199-1203.
11. Tallarida RJ, Porreca F, Cowan A. Statistical analysis of drug-drug and site-site interactions with isobologram. Life Sci. 1989;46:947-961.
12. Kohno T, Wakai A, Ataka T, Ikoma M, Yamakura T, Baba H. Actions of midazolam on excitatory transmission in dorsal horn neurons of adult rat spinal cord. Anesthesiology. 2006;104:338-343.
13. Rudomin P. Primary afferent depolarization produced in A delta and C fibres by glutamate spillover? New ways to look at old things. J Physiol. 2000;528:1.
14. Clavier N, Lombard MC, Besson JM. Benzodiazepines and pain: Effects of midazolam on the activities of nociceptive non-specific dorsal horn neurons in the rat spinal cord. Pain. 1992;48:61-71.
15. Rogers DT, Iwamoto ET. Multiple spinal mediators in parenteral nicotine-induced antinociception. J Pharmacol Exp Ther. 1993;267:341-349.
16. 3H] acetylcholine binding sites in the cervical spinal cord of man and some other species. Neurosci Lett. 1988;90:197-202.
17. Laing I, Todd AJ, Heizmann CW, Schmidt HH. Subpopulations of GABAergic neurons in laminae I-III of rat spinal dorsal horn defined by coexistence with classical transmitters, peptides, nitric oxide synthase or parvalbumin. Neuroscience. 1994;61:159-166.
18. Todd AJ. Immunohistochemical evidence that acetylcholine and glycine exist in different populations of GABAergic neurons in lamina III of rat spinal dorsal horn. Neuroscience. 1991;44:741-746.
19. Curzon P, Nikkel AL, Bannon AW, Arneric SP, Decker MW. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (±)-epibatidine in rats. J Pharmacol Exp Ther. 1998;287:847-853.
20. Flores CM, Wilson SG, Mogil JM. Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception. Pharmacogenetics. 1999;9:619-625.
21. Badio B, Daly JW. Epibatidine, a potent analgesic and nicotinic agonist. Mol Pharmacol. 1994;45:563-569.
22. Rao TS, Correa LD, Reid RT, Lloyd GK. Evaluation of antinociceptive effects of neuronal nicotinic acetylcholine receptor (nAChR) ligands in the rat tail-flick assay. Neuropharmacology. 1996;35:393-405.
23. Rupniak NMJ, Patel S, Marwood R, Webb J, Traynor JR, Elliott J, Freedman SB, Fletcher SR, Hill RG. Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity. Br J Pharmacol. 1994;113:1487-1493.
24. Sullivan JP, Decker MW, Brioni JD, Donnelly-Roberts D, Anderson DJ, Kang CH, Adams P, Piattoni-Kaplan M, Buckley MJ. (±)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 1994;271:624-631.
25. Advokat C, Rutherford D. Selective antinociceptive effect of excitatory amino acid antagonists in intact and acute spinal rats. Pharmacol Biochem Behav. 1995;51:855-860.
26. Khan IM, Yaksh TL, Taylor P. Epibatidine binding sites and activity in the spinal cord. Brain Res. 1997;753:269-282.
27. Puig S, Sorkin LS. Formalin-evoked activity in identified primary afferent fibres: Systemic lidocaine suppresses phase 2 activity. Pain. 1996;64:345-357.
28. Li J, Simone DA, Larson A. Windup leads to characteristics of central sensitization. Pain. 1999;79:75-82.